PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
NCT03079011
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1017
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Palbociclib 125mg
DRUG:
Aromatase Inhibitors
DRUG:
Fulvestrant Injectable Product
Sponsor
UNICANCER
Collaborators
[object Object]